483
HP Halden Pharma ASHP Halden Pharma AS – FDA 483, Sep 3, 2019
Record Details
Fresenius Kabi Norge As, a sterile drug manufacturer in Halden, Norway, was cited for three observations related to quality system deficiencies. The firm failed to submit a Field Alert Report for a distributed drug product that failed stability specifications and did not thoroughly review batch failures. Additionally, the quality control unit's procedures for characterizing particles found during AQL testing were not adequately documented or followed.
View Company Profile
ID · 0b8630dc-a7eb-4b55-84fd-80f62b916fda
Other documents for HP Halden Pharma AS
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.